Interaction between bacterial peptides, neutrophils and goblet cells: A possible mechanism for neutrophil recruitment and goblet cell depletion in colitis

Clinical Science

Volumn 101, Issue 4, 2001, Pages 395-402

  Leiper, K ^a   Campbell, B J ^a   Jenkinson, M O ^a   Milton, J ^a   Yu, L G ^a   Democratis, J ^a   Rhodes, J M ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Colitis; FMLP; Mucus; Neutrophil

Indexed keywords

[4 (4 BROMOPHENYLSULFONYLCARBAMOYL)BENZOYL]VALYLPROLINE N (2 METHYL 1 TRIFLUOROACETYLPROPYL)AMIDE; BACTERIAL PROTEIN; CHEMOKINE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; INTERLEUKIN 8; LEUKOCYTE ELASTASE;

ARTICLE; CELL ACTIVATION; CELL INTERACTION; CELL SECRETION; COLITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EPITHELIUM CELL; GOBLET CELL; HUMAN; HUMAN CELL; HYPOTHESIS; INFLAMMATION; MUCUS SECRETION; NEUTROPHIL; PRIORITY JOURNAL;

BACTERIAL PROTEINS; COLITIS; COLON; DOSE-RESPONSE RELATIONSHIP, DRUG; GOBLET CELLS; HUMANS; INTERLEUKIN-8; MUCINS; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHIL ACTIVATION; TUMOR CELLS, CULTURED;

EID: 0034816061     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20010078     Document Type: Article

References (62)

1. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats
2. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease
3. The intestinal mucus layer from patients with inflammatory bowel disease harbors high numbers of bacteria compared with controls
4. Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn's disease
5. Formyl-methionyl-leucyl-phenylalanine and the SOS operon in Escherichia coli: A model of host-bacterial interactions
6. Radioimmunoassay for formyl methionyl leucyl phenylalanine. II. Demonstration of an enterohepatic circulation of immunoreactive bacterial chemotactic peptides in man
7. Purification and identification of formyl-methionyl-leucyl-phenylalanine as the major peptide neutrophil chemotactic factor produced by Escherichia coli
8. Acute colitis produced by chemotactic peptides in rats and mice
9. Chemotactic peptides. Mechanisms, functions and possible role in inflammatory bowel disease
10. Mucosal subepithelial binding sites for the bacterial chemotactic peptide, formyl-methionyl-leucyl-phenylalanine (FMLP)
11. hPepT1-mediated epithelial transport of bacteria-derived chemotactic peptides enhances neutrophil-epithelial interactions
12. Oligopeptide transporter PepT1 mRNA expression in human intestinal mucosa: Gut gradient, cellular localization and colonic upregulation in short bowel syndrome
13. Interleukin-8 and MCAF: Novel leukocyte recruitment and activating cytokines
14. IL-8 secretion and neutrophil activation by HT-29 colonic epithelial cells
15. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils
16. Neutrophil migration across monolayers of cytokine-prestimulated endothelial cells: A role for platelet-activating factor and IL-8
17. Production of chemokines, interleukin-8 and monocyte chemoattractant protein-1, during monocyte-endothelial cell interactions
18. Differential cytokine expression by human intestinal epithelial cell lines: Regulated expression of IL-8
19. Colonic epithelial cell lines as a source of interleukin-8: Stimulation by inflammatory cytokines and bacterial lipopolysaccharides
20. Epithelial cells secrete the chemokine interleukin 8 in response to bacterial entry
21. Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease
22. Increased interleukin 8 (IL-8) in the rectal dialysate from patients with ulcerative colitis: Evidence for a biological role for IL-8 in inflammation of the colon
23. Signal transduction, packaging and secretion of mucins
24. The T84 human colonic adenocarcinoma cell line produces mucin in culture and releases it in response to various secretagogues
25. Mechanism of rapid mucus secretion in goblet cells stimulated by acetylcholine
26. Both crypt and villus intestinal goblet cells secrete mucin in response to cholinergic stimulation
27. 2+
28. Neurotensin and neuromedin N stimulate mucin output from human goblet cells via neurotensin receptors
29. Functional VIP receptors in the human mucus secreting cell line CL.16E
30. Regulation of intestinal goblet cell secretion II. A survey of potential secretagogues
31. Interleukin 1 is a mucus secretagogue
32. A novel human macrophage-derived intestinal mucin secretagogue: Implications for the pathogenesis of inflammatory bowel disease
33. Mucus hypersecretion in bronchiectasis. The role of neutrophil proteases
34. Mucin depletion in inflammatory bowel disease
35. Guidelines for the initial diagnosis of suspected idiopathic inflammatory bowel disease. The British Society of Gastroenterology initiative
36. Histopathology differentiates acute self limiting colitis from ulcerative colitis
37. Acute irradiation proctitis in man
38. Experimental models of inflammatory bowel disease
39. Histopathology of Crohn's disease
40. Studies on the mechanism of mucous cell depletion in experimental colitis
41. Growth adaptation to methotrexate of HT-29 human colon carcinoma cells is associated with their ability to differentiate into columnar absorptive and mucus-secreting cells
42. Inhibition of human neutrophil elastase by ICI 200,355
43. Colonic mucin synthesis is increased by sodium butyrate
44. High performance gel filtration using monodisperse highly cross linked agarose as a one step system for mucin purification
45. A simple, rapid, and sensitive DNA assay procedure
46. IL-8 and NAP-2 differ in their capacities to bind and chemoattract 293 cells transfected with either IL-8 receptor type A or type B
47. Effects of cytokines, without and with Helicobacter pylori components, on mucus secretion by cultured gastric epithelial cells
48. Bradykinin and FMLP stimulate prostanoid production by adult rabbit colonocytes in culture
49. Substrate upregulation of the human small intestinal peptide transporter, hPepT1
50. Mapping of genes for the human C5a receptor (C5AR), human FMLP receptor (FPR), and two FMLP receptor homologue orphan receptors (FPRH1, FPRH2) to chromosome 19
51. Neutrophil elastase and cathepsin G stimulate tracheal submucosal gland secretion from bovine airway gland serous cells
52. Neutrophil elastase stimulates tracheal submucosal gland secretion that is inhibited by ICI 200, 355
53. Mechanisms of airway goblet cell mucin release: Studies with cultured tracheal surface epithelial cells
54. Regulation of human airway mucins by acrole and inflammatory mediators
55. Cell surface bound elastase and cathepsin G on human neutrophils. A novel, non oxidative mechanism by which neutrophils focus and preserve catalytic activity of serine proteases
56. Cytokines regulate membrane-bound leukocyte elastase on neutrophils: A novel mechanism for effector activity
57. Leucocyte function in Crohn's disease
58. Serum inhibitors of neutrophil chemotaxis in Crohn's disease and ulcerative colitis
59. Neutrophil dysfunction in Crohn's disease
60. Gastrointestinal manifestations of chronic granulomatous disease
61. Inflammatory bowel disease in glycogen storage disease type 1b
62. Lectins, colitis and inflammatory bowel disease